142 related articles for article (PubMed ID: 36720509)
1. Extrarenal rhabdoid tumour of axillary soft tissue: a diagnostic challenge resolved by immunohistochemistry.
Buch AC; Bhuibhar G; Londhe M; Dhaliwal S; Gurwale S
BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36720509
[TBL] [Abstract][Full Text] [Related]
2. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
Oda Y; Tsuneyoshi M
Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
[TBL] [Abstract][Full Text] [Related]
3. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
4. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
[TBL] [Abstract][Full Text] [Related]
5. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
6. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
7. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.
Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C
Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520
[TBL] [Abstract][Full Text] [Related]
8. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
9. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.
Kreiger PA; Judkins AR; Russo PA; Biegel JA; Lestini BJ; Assanasen C; Pawel BR
Mod Pathol; 2009 Jan; 22(1):142-50. PubMed ID: 18997735
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
[TBL] [Abstract][Full Text] [Related]
11. Congenital Disseminated Extrarenal Malignant Rhabdoid Tumor.
Boudjemaa S; Petit A; Dainese L; Bourdeaut F; Lipsett J; Coulomb A
Pediatr Dev Pathol; 2015; 18(5):401-4. PubMed ID: 25751458
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
Rekhi B; Jambhekar NA
Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
[TBL] [Abstract][Full Text] [Related]
13. [Rhadboid tumours: hSNF/INI1 deficient cancers of early childhood with aggressive behaviour].
Bourdeaut F; Dufour C; Delattre O
Bull Cancer; 2010 Jan; 97(1):37-45. PubMed ID: 20080459
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.
Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA
Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652
[TBL] [Abstract][Full Text] [Related]
15. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
[TBL] [Abstract][Full Text] [Related]
16. Congenital extrarenal malignant rhabdoid tumor in an infant with distal 22q11.2 deletion syndrome: the importance of SMARCB1.
Chakrapani AL; White CR; Korcheva V; White K; Lofgren S; Zonana J; Moore S; Krol A; Mansoor A
Am J Dermatopathol; 2012 Aug; 34(6):e77-80. PubMed ID: 22814326
[TBL] [Abstract][Full Text] [Related]
17. SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?
Russo P; Biegel JA
Pediatr Blood Cancer; 2009 Mar; 52(3):312-3. PubMed ID: 19072985
[No Abstract] [Full Text] [Related]
18. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
[TBL] [Abstract][Full Text] [Related]
19. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
20. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
